Abstract
Although most patients with locoregional cancer are cured by surgery, radiotherapy, chemotherapy, and combinations thereof, those with distant metastases are not despite systemic chemotherapy. These patients respond to local radiotherapy but generally need systemic therapy. Non-Hodgkin's lymphoma (NHL) provides a paradigm for the role of molecular targeted radiotherapy (MTRT) because these patients have multifocal disease in most cases. Although patients with NHL achieve remissions after multiple cycles of chemotherapy, less than one half of those with aggressive NHL are cured and almost none of those with low grade NHL. Furthermore, NHL, like other cancers, becomes chemoresistant, yet remains responsive to radiotherapy. MTRT, radiation targeted by molecules, is a good strategy for the treatment of multifocal and radiosensitive cancers. Radioimmunotherapy (RIT) is an MTRT approach using MAbs, or parts thereof, to target the radionuclide that delivers radiation. Two anti-CD20 monoclonal antibodies (MAbs), one labeled with (111)In for imaging or (90)Y for therapy and a second labeled with (131)I for imaging and therapy, have proven effective and safe for MTRT for NHL patients. The importance of the radiation is demonstrated in th...Continue Reading
References
May 2, 1990·Journal of the National Cancer Institute·J SchlomD Colcher
Oct 1, 1974·Cancer·R J Lukes, R D Collins
Mar 4, 1982·The New England Journal of Medicine·R A MillerR Levy
Aug 5, 1995·Lancet·O W PressT Gooley
Feb 1, 1994·Cancer·G L DeNardoC F Meares
Feb 1, 1994·Cancer·G L DeNardoL A Kroger
Jan 1, 1997·Nuclear Medicine and Biology·S ShenK R Lamborn
Dec 24, 1997·Cancer·D A Goodwin, C F Meares
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·D B AxworthyA R Fritzberg
Oct 6, 2001·Blood·O W PressD Axworthy
Oct 18, 2001·Cancer Biotherapy & Radiopharmaceuticals·R F MeredithA F LoBuglio
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Mar 6, 2002·Cancer·Gerald L DeNardoSally J DeNardo
May 10, 2003·Blood·Oliver W PressRichard I Fisher
May 17, 2003·Blood·Ajay K GopalOliver W Press
May 1, 1953·Cancer·D PRESSMAN, L KORNGOLD
Jul 1, 1956·Cancer·E B HICKSW J WINTER
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Torsten LierschDavid M Goldenberg
Nov 1, 2005·Nature Medicine·Robert M SharkeyDavid M Goldenberg
Dec 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M GoldenbergJean-François Chatal
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-François ChatalUNKNOWN French Endocrine Tumor Group
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Edmund A RossiChien-Hsing Chang
Sep 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Gerald L DeNardoSally J DeNardo
May 29, 2007·Oncogene·D M Goldenberg, R M Sharkey
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rod BalhornGerry L DeNardo
Mar 18, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nirav S KapadiaRichard L Wahl
Jul 3, 2008·Cancer Biotherapy & Radiopharmaceuticals·Michael G Stabin
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Franck MorschhauserAnton Hagenbeek
Dec 1, 2008·Cancer Biotherapy & Radiopharmaceuticals·Gerald L DeNardoRod Balhorn